Obesity and Type 2 Diabetes Clinical Trials
2 recruiting trials for Obesity and Type 2 Diabetes. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Obesity and Type 2 Diabetes clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Syracuse University (1), Changi General Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is High-intensity interval training (behavioral, 1 trial), followed by Time-restricted eating, OneSTOP program.
Track Obesity and Type 2 Diabetes trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on...
OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities
The goal of this clinical trial is to learn if the use of a care model including teleconsults and the EMPOWER app can induce clinically significant weight loss and metabolic...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Obesity and Type 2 Diabetes, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Obesity and Type 2 Diabetes, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Obesity and Type 2 Diabetes, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.